Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma (Q36792006)

16 August 2017

Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma (English)

1 reference

16 August 2017

Elizabeth Garrett-Mayer

object named as

Elizabeth Garrett-Mayer

2

0 references

author name string

Robert L Giuntoli

1

1 reference

16 August 2017

Robert E Bristow

3

1 reference

16 August 2017

Bobbie S Gostout

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

16 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

106

1 reference

16 August 2017

1

1 reference

16 August 2017

82-88

1 reference

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Uterine smooth-muscle tumors of uncertain malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Phase II trial of paclitaxel in leiomyosarcoma of the uterus: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Temozolomide in uterine leiomyosarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Resection of pulmonary metastases from uterine sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Surgical Resection of Pulmonary and Extrapulmonary Recurrences of Uterine Leiomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Some recent developments for regression analysis of multivariate failure time data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Secondary cytoreduction for ovarian cancer following cisplatin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Secondary cytoreductive surgery for recurrent epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

7 January 2021

Uterine leiomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.031

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2007.02.031

1 reference

16 August 2017

1 reference